Status:
COMPLETED
Radiotherapy of Tongue Cancer Using an Intraoral Stent
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
Oslo Metropolitan University
Conditions:
Tongue Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
Radiotherapy of tongue cancer is associated with acute and late morbidity. Use of an intraoral stent will provide a larger distance between the tongue and palate and can reduce side-effects. The aim o...
Detailed Description
Radiotherapy of tongue cancer is associated with acute and late morbidity. Use of an intraoral stent will provide a larger distance between the tongue and palate and can reduce side-effects. The main ...
Eligibility Criteria
Inclusion
- Patients with tongue cancer
- Curatively intended radiotherapy requiring a total dose of 50-70 Gy
- Age \>18 years
- Performance status, Eastern Cooperative Oncology Group (ECOG) 0-2
Exclusion
- None
Key Trial Info
Start Date :
March 9 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 4 2018
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT04337853
Start Date
March 9 2018
End Date
December 4 2018
Last Update
November 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital
Oslo, Norway, N-0424